News & Events

We are pleased to announce that our Working Group members have published a new paper in the jounal, Basic & Clinical Pharmacology & Toxicology entitled: “Quality Assessment of Therapeutic Drug…

📢 New Publication from the Members of ENOTTA in the British Journal of Clinical Pharmacology We are proud to announce that ENOTTA members have published the paper “Therapeutic drug monitoring…

The Extended Core Group Meeting of the ENOTTA (CA21147) COST Action was successfully held on 10–12 September 2025 in Berlin, Germany. Over the course of three highly productive days, core…

Call for Applications – ENOTTA Biomarkers Training School COST Action ENOTTA (CA21147) is excited to invite applications for the Biomarkers Training School, taking place 4–6 February 2026 at the University…

The Extended Core Group Meeting of the ENOTTA (CA21147) COST Action was successfully organized at he Galata University in the beautiful city of Istanbul, Turkiye from 28–30 May 2025. Over…

The Training School on Model-Informed Precision Dosing, organized by COST Action ENOTTA, was successfully held at KU Leuven on 23-25 April. With a focus on monoclonal antibody dosing in chronic immune-mediated inflammatory diseases,…

🎉 Exciting Updates from ENOTTA! 🎉 We are thrilled to announce two new appointments to our COST Action ENOTTA team: 1️⃣ Prof. Güldal İnal Gültekin joins us as the Co-Leader…

We are excited to announce the start of a new webinar series organized by Working Group 4 (WG-4) of ENOTTA. This series, titled “Pharmacoeconomics in Therapeutic Drug Monitoring of Antibodies…

COST Action ENOTTA, the European Network on Optimising Treatment with Therapeutic Antibodies in chronic inflammatory diseases (CA21147), is pleased to announce a unique opportunity for researchers and healthcare practitioners to…

We are excited to announce a leadership change in ENOTTA Working Group 3, “Assay Standardisation and Structured Overview on Participating Hospitals/Research Centres.” We extend our heartfelt gratitude to Prof. Silje…